all report title image
  • Published On : Jul 2022
  • Code : CMI5078
  • Industry : Medical Devices
  • Pages : 167
  • Formats :

Defibrillators are medical devices used to defibrillate or stabilize the heartbeat of an individual in a condition of arrhythmias (irregular heartbeat) and ventricular tachycardia (a heart rhythm disorder). Automated external defibrillators (AEDs) are used to revive someone from sudden cardiac arrest. AEDs are portable, life-saving devices used to treat people experiencing sudden cardiac arrest, a serious heart condition. Most cardiac arrests occur when the heart's electrical system malfunctions. Thus, with the increasing prevalence of cardiac disorders, such as stroke and heart attack, the demand for defibrillators is also increasing.

Market Statistics:

The global automated external defibrillator market was valued at US$ 717.5 Mn in 2021 and is forecast to reach a value of US$ 1,217.0 Mn by 2028 at a CAGR of 7.8% between 2022 and 2028.

North America held dominant position in the global automated external defibrillator market in 2020, accounting for 55.0% share in terms of volume, followed by Europe and Asia Pacific, respectively.

Figure 1. Global Automated External Defibrillator Market Share (%), by Region, 2022

Automated External Defibrillator  | Coherent Market Insights

Recent Developments:

In April 2021, ZOLL Medical Corporation acquired Respicardia, Inc., the company has sought to expand in the area such as heart failure, with this acquisition, focused on cardiopulmonary resuscitation, such as defibrillators, AEDs, and LifeVest wearable defibrillators.

In June 2020, Royal Philips received the United States Food and Drug Administration (FDA) premarket approval for HeartStart FR3 and HeartStart FRx automated external defibrillators, and their supporting accessories, including batteries and pads.

In September 2019, Shenzhen Mindray launched BeneHeart C Series AED with new features and provides faster shock delivery to achieve better resuscitation outcomes for sudden cardiac arrest (SCA). It is now available in Europe and other selected countries.

Market Drivers:

  1. Increasing prevalence of cardiovascular diseases (CVDs) across the globe is expected to aid in the growth of the global automated external defibrillator market over the forecast period. For instance, according to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. More than four out of five CVD deaths are due to heart attacks and strokes, and one third of these deaths occur prematurely in people under 70 years of age.
  2. Increasing training and awareness programs regarding defibrillators is expected to augment the growth of the global automated external defibrillator market during the forecast period. For instance, in March 2021, GAA launched defibrillator awareness programme. The programme allows clubs to fundraise for new AEDs, which are connected to the internet through the mobile phone network. This means automated external defibrillators will check and notify via email if there is an issue that needs to be addressed.
CMI table icon

Automated External Defibrillator Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2021: US$ 2,080.6 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2028
Forecast Period 2022 to 2028 CAGR: 7.8% 2028 Value Projection: US$ 1,217.0 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Analysis Type: Semi-automated External Defibrillators and Fully-automated External Defibrillators
  • By End User: Hospitals/Clinics, Home Care, and Other End Users
Companies covered:

CU Medical System Inc., ViVest Medical, BPL Medical Technologies Pvt. Ltd., Mediana Co. Ltd., Stryker Corporation, Schiller AG, Nihon Kohden Corporation, Koninklijke Philips NV, Asahi Kasei Corporation, and Shenzhen Mindray Bio-Medical Electronics Co. Ltd., among others

Growth Drivers:
  • Increasing prevalence of cardiovascular diseases
  • Increasing awareness among people about defibrillators
Restraints & Challenges:
  • Stringent rules and regulations regarding medical devices
  • Lack of awareness about sudden cardiac arrest

Figure 2. Global Automated External Defibrillator Market Share (%), by Analysis Type, 2022

Automated External Defibrillator  | Coherent Market Insights

Market Restraints:

  1. Stringent rules/regulations regarding medical devices, including AEDs, is expected to hinder growth of the global automated external defibrillator market. For instance, according to the US Food & Drug Administration (FDA), manufacturers are required to obtain premarket approval for all AEDs to ensure the quality and reliability of AEDs.
  2. Lack of awareness and early corrective measures about sudden cardiac arrest is expected to hamper growth of the global automated external defibrillator market. For instance, many other medical conditions or lifestyles can put people at high risk of heart diseases, including diabetes, obesity and overweight, unhealthy diet, physical inactivity, and high alcohol consumption.

Market Opportunities:

  1. Rising geriatric population around the world is expected to offer lucrative opportunities for players in the global automated external defibrillator market. Geriatric population is associated with progressive deterioration in the structure and function of the heart and acts as a catalyst in the development of chronic diseases. For instance, according to WHO, by 2030, 1 in 6 people in the world will be aged 60 years or over, and by 2050, the world’s population of people aged 60 years and older will double (2.1 billion).
  2. Technological advancements in the field of AEDs is expected to offer lucrative opportunities for players in the global automated external defibrillator market. For instance, in April 2019, Stryker launched the company’s newest defibrillation solution, the LIFEPAK CR2 defibrillator with LIFELINKcentral AED program manager, in the United States. The LIFEPAK CR2 is designed to help rescuers provide higher quality CPR and to provide the fastest first shock when defibrillation is needed.

Market Trends/Key Takeaways:

  1. Increasing demand or adoption of AEDs is expected to drive growth of the global automated external defibrillator market. For instance, in September 2021, ZOLL MEDICAL announced the launch of three automated external defibrillator (AED) models to penetrate the Thai market. This estimated that demand for AEDs in Thailand would rise to 10,000 units.
  2. Frequent approvals and launches of novel products is expected to propel growth of the global automated external defibrillator market. For instance, in June 2020, Royal Philips announced that the FDA has granted premarket approval for the company’s HeartStart FR3 and HeartStart FRx automated external defibrillators (AEDs).

Competitive Landscape:

  1. Asahi Kasei Corporation
  2. Koninklijke Philips NV
  3. Nihon Kohden Corporation
  4. Schiller AG
  5. Shenzhen Mindray Bio-Medical Electronics Co. Ltd
  6. Stryker Corporation
  7. CU Medical System Inc.
  8. Mediana Co. Ltd.
  9. BPL Medical Technologies Pvt. Ltd.
  10. ViVest Medical

Automated external defibrillators (AEDs) are used to treat people experiencing sudden cardiac arrest, a medical condition in which the heart stops beating suddenly and unexpectedly. AEDs send an electric pulse or shock to the heart to restore a normal heartbeat. AED is used to both analyze the electrical cardiac rhythm and deliver shocks. They are often used to revive someone from sudden cardiac arrest or to help those experiencing sudden cardiac arrest. Thus, with the increase in prevalence of cardiac diseases, the demand for AEDs is also increasing.

Market Dynamics:

High prevalence of cardiovascular diseases (CVDs), growing geriatric population, and increase in awareness among people about cardiac health is expected to boost the growth of the global automated external defibrillator market during the forecast period. CVDs are the most frequent condition in older adults and the No. 1 cause of death. Adults age 65 and older are more likely than younger people to suffer from cardiovascular disease. For instance, according to the World Health Organization (WHO), 1 in 6 people worldwide will be aged 60 years or over by 2030, and by 2050, the world’s population aged 60 years and older will double (2.1 billion).

Key features of the study:

  • This report provides in-depth analysis of the global automated external defibrillator market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global automated external defibrillator market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include CU Medical System Inc., ViVest Medical, BPL Medical Technologies Pvt. Ltd., Mediana Co. Ltd., Stryker Corporation, Schiller, Nihon Kohden Corporation, Koninklijke Philips, Asahi Kasei Corporation, and Shenzhen Mindray Bio-Medical Electronics Co. Ltd., among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global automated external defibrillator market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global automated external defibrillator market.

Detailed Segmentation:

  • Global Automated External Defibrillator Market, By Analysis Type:
    • Semi-automated External Defibrillators
    • Fully-automated External Defibrillators
  • Global Automated External Defibrillator Market, By End User:
    • Hospitals/Clinics
    • Home Care
    • Other End Users
  • Global Automated External Defibrillator Market, By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Middle East & Africa
    • South America

Frequently Asked Questions

The global automated external defibrillator market size is estimated to be valued at US$ 773.3 Million in 2022 and is expected to exhibit a CAGR of 7.8% between 2022 and 2028.
Increasing prevalence of cardiovascular diseases and increasing awareness among people about defibrillators are fueling the growth of the market.
The Semi-automated external defibrillators segment is the leading analysis type segment in the market.
Stringent rules and regulations regarding medical devices and lack of awareness about sudden cardiac arrest are major factors restraining growth of the market.
Major players operating in the market are CU Medical System Inc., ViVest Medical, BPL Medical Technologies Pvt. Ltd., Mediana Co. Ltd., Stryker Corporation, Schiller AG, Nihon Kohden Corporation, Koninklijke Philips NV, Asahi Kasei Corporation, and Shenzhen Mindray Bio-Medical Electronics Co. Ltd., among others.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo